Assessment of Serum Concentrations of Ghrelin, Obestatin, Omentin-1, and Apelin in Children with Type 1 Diabetes

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Polkowska, Agnieszka ^a   Szczepaniak, Izabela ^a   Bossowski, Artur ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; GHRELIN; HEMOGLOBIN A1C; OBESTATIN; OMENTIN 1; PROTEIN; THYROID ANTIBODY; THYROTROPIN; UNCLASSIFIED DRUG; APLN PROTEIN, HUMAN; CYTOKINE; GLUCOSE BLOOD LEVEL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INSULIN; ITLN1 PROTEIN, HUMAN; LECTIN; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; AGE; ANTHROPOMETRY; BODY HEIGHT; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; BLOOD; BODY MASS; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; KETOACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GHRELIN; GPI-LINKED PROTEINS; HUMANS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KETOSIS; LECTINS; MALE;

EID: 84958576881     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/8379294     Document Type: Conference Paper

References (28)

1. B. Sawicka, A. Bossowski, M. Szalecki et al. , "Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases, " Journal of Pediatric Endocrinology and Metabolism, vol. 23, no. 4, pp. 345-354, 2010.
2. A. Bossowski, B. Czarnocka, J. Harasymczuk et al. , "Identification of GPR39 receptor and ghrelin receptor in thyroid tissues in paediatric patients with immune and non-immune thyroid diseases, " Hormone Research in Paediatrics, vol. 79, no. 3, pp. 130-136, 2013.
3. R.-Z. Yang, M.-J. Lee, H. Hu et al. , "Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action, " American Journal of Physiology-Endocrinology and Metabolism, vol. 290, no. 6, pp. E1253-E1261, 2006.
4. A. Fukuhara, M. Matsuda, M. Nishizawa et al. , "Visfatin: a protein secreted by visceral fat that mimics the effects of insulin, " Science, vol. 307, no. 5708, pp. 426-430, 2005.
5. H. J. Yoo, S. Y. Hwang, H. C. Hong et al. , "Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes, " Cardiovascular Diabetology, vol. 10, article 103, 2011.
6. C. M. de Souza Batista, R.-Z. Yang, M.-J. Lee et al. , "Omentin plasma levels and gene expression are decreased in obesity, " Diabetes, vol. 56, no. 6, pp. 1655-1661, 2007.
7. C. Dray, C. Knauf, D. Daviaud et al. , "Apelin stimulates glucose utilization in normal and obese insulin-resistant mice, " Cell Metabolism, vol. 8, no. 5, pp. 437-445, 2008.
8. D. K. Lee, R. Cheng, T. Ngyuen et al. , "Characterization of apelin, the ligand for the APJ receptor, " Journal of Neurochemistry, vol. 74, no. 1, pp. 34-41, 2000.
9. M. A. Lazarczyk, M. Lazarczyk, and T. Grzela, "Ghrelin: a recently discovered gut-brain peptide, " International Journal of Molecular Medicine, vol. 12, no. 3, pp. 279-287, 2003.
10. T. R. Castañeda, J. Tong, R. Datta, M. Culler, and M. H. Tschp, "Ghrelin in the regulation of body weight and metabolism, " Frontiers in Neuroendocrinology, vol. 31, no. 1, pp. 44-60, 2010.
11. N. Delzenne, J. Blundell, F. Brouns et al. , "Gastrointestinal targets of appetite regulation in humans, " Obesity Reviews, vol. 11, no. 3, pp. 234-250, 2010.
12. I. Depoortere, T. Thijs, D. Moechars, B. De Smet, L. Ver Donck, and T. L. Peeters, "Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice, " British Journal of Pharmacology, vol. 153, no. 7, pp. 1550-1557, 2008.
13. A. Ikezaki, H. Hosoda, K. Ito et al. , "Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents, " Diabetes, vol. 51, no. 12, pp. 3408-3411, 2002.
14. S. Tapan, E. Tascilar, A. Abaci et al. , "Decreased plasma apelin levels in pubertal obese children, " Journal of Pediatric Endocrinology and Metabolism, vol. 23, no. 10, pp. 1039-1046, 2010.
15. K. Ziora, J. Owiecimska, E. wietochowska et al. , "Assessment of serumapelin levels in girls with anorexia nervosa, " Journal of Clinical Endocrinology andMetabolism, vol. 95, no. 6, pp. 2935-2941, 2010.
16. H. Zamrazilov, V. Hainer, D. Sedlckov? et al. , "Plasma obestatin levels in normal weight, obese and anorectic women, " Physiological Research, vol. 57, supplement 1, pp. S49-S55, 2008.
17. T. Reinehr, J. Woelfle, and C. L. Roth, "Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis, " Metabolism: Clinical and Experimental, vol. 60, no. 9, pp. 1349-1354, 2011.
18. L. H. Duntas, J. Orgiazzi, and G. Brabant, "The interface between thyroid and diabetes mellitus, " Clinical Endocrinology, vol. 75, no. 1, pp. 1-9, 2011.
19. Y. H. Cho, M. E. Craig, and K. C. Donaghue, "Puberty as an accelerator for diabetes complications, " Pediatric Diabetes, vol. 15, no. 1, pp. 18-26, 2014.
20. W. Modrzejewski and W. J. Musia?, "Old and newcardiovascular risk factor-how to stop an epidemic of atherosclerosis Part1. Classical risks, " Forum Zaburzen Metabolicznych, vol. 1, no. 2, pp. 106-114, 2010.
21. R.-E. W. Kavey, S. R. Daniels, R. M. Lauer, D. L. Atkins, L. L. Hayman, and K. Taubert, "American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood, " Circulation, vol. 107, no. 11, pp. 1562-1566, 2003.
22. C. Giannini, A. Mohn, F. Chiarelli, and C. J. H. Kelnar, "Macrovascular angiopathy in children and adolescents with type 1 diabetes, "Diabetes/MetabolismResearch and Reviews, vol. 27, no. 5, pp. 436-460, 2011.
23. G. Broda, "Zapobiegamiazdzycywdziecistwie, aby zachowa? zdrowie w dalszych latach zycia, " Kardiologia Polska, vol. 69, no. 6, pp. 546-547, 2011.
24. C. Giannattasio, M. Failla, A. Piperno et al. , "Early impairment of large artery structure and function in Type I diabetes mellitus, " Diabetologia, vol. 42, no. 8, pp. 987-994, 1999.
25. A. G. Japp, N. L. Cruden, G. Barnes et al. , "Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure, " Circulation, vol. 121, no. 16, pp. 1818-1827, 2010.
26. E. A. Ashley, J. Powers, M. Chen et al. , "The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo, " Cardiovascular Research, vol. 65, no. 1, pp. 73-82, 2005.
27. F.-J. Shang, J.-P. Wang, X.-T. Liu et al. , "Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome, " Biomarkers, vol. 16, no. 8, pp. 657-662, 2011.
28. M. M. Malagn, R. M. Luque, E. Ruiz-Guerrero et al. , "Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes, " Endocrinology, vol. 144, no. 12, pp. 5372-5380, 2003.